XML 24 R14.htm IDEA: XBRL DOCUMENT v3.5.0.2
9. Segment and Geographic Information
 6 Months Ended
Sep. 30, 2016
Segment Reporting [Abstract]  
Segment and Geographic Information

The Company generates product revenues from wound care products that are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services, which are provided to medical device manufacturers.

 

The Company operates a single segment business for product revenues, which consists of three geographical sales territories as follows:

 

   Three Months   Six Months 
   Ended   Ended 
   September 30,   September 30, 
Geographic region  2016   2015   2016   2015 
United States  $1,697,000   $1,186,000   $3,070,000   $1,973,000 
Latin America   1,192,000    1,266,000    2,290,000    2,824,000 
Europe and Rest of World   920,000    952,000    1,958,000    1,523,000 
    3,809,000    3,404,000    7,318,000    6,320,000 
Product license fees and royalties   75,000    339,000    150,000    786,000 
Total product related revenues  $3,884,000   $3,743,000   $7,468,000   $7,106,000 

 

The following table shows the Company’s product license fees and royalties revenues by partner:

  

   Three Months   Six Months 
   Ended   Ended 
   September 30,   September 30, 
Partner  2016   2015   2016   2015 
Exeltis  $–   $103,000   $–   $157,000 
Innovacyn   –    9,000    –    29,000 
Laboratorios Sanfer (affiliate of Invekra)   75,000    227,000    150,000    600,000 
Total product license fees and royalties  $75,000   $339,000   $150,000   $786,000 

 

The Company’s service revenues amounted to $224,000 and $311,000 for the three months ended September 30, 2016 and 2015, respectively.

 

The Company’s service revenues amounted to $451,000 and $628,000 for the six months ended September 30, 2016 and 2015, respectively.